Target intelligence / Profile preview

2-haloacid dehalogenase (2-HAD)

Target
2-HAD
Molecular classification
Enzyme, Hydrolase, Haloacid dehalogenase-like (HAD) superfamily
01

Overview

2-haloacid dehalogenase (EC 3.8.1.2) is a microbial enzyme that catalyzes the hydrolytic cleavage of carbon-halogen bonds in 2-haloalkanoic acids, converting them into 2-hydroxyalkanoic acids and halide ions (UniProt P22910). This enzyme is a key component in the biodegradation of halogenated organic compounds, such as chloroacetate and 2-chloropropionate, which are common environmental pollutants and components of certain herbicides (PubMed: 11473118). Based on their stereospecificity, these enzymes are categorized into L-specific, D-specific, and non-stereospecific types, each employing a nucleophilic substitution mechanism often involving a conserved aspartate residue (PubMed: 10480877). While 2-haloacid dehalogenases are not currently utilized as therapeutic targets for human disease, they are of significant interest in biotechnology for bioremediation and the industrial production of optically active chemicals. They belong to the broader Haloacid Dehalogenase-like (HAD) superfamily, which includes various phosphatases and hydrolases found across all domains of life, though the specific 2-haloacid dehalogenase activity is primarily associated with bacteria and archaea (BRENDA: EC 3.8.1.2).

Other names
L-2-haloacid dehalogenaseD-2-haloacid dehalogenase2-haloalkanoic acid dehalogenaseHaloacetate dehalogenaseDL-2-haloacid dehalogenase
02

Mechanism of action

Catalytic hydrolysis of carbon-halogen bonds via a nucleophilic substitution mechanism, typically involving a conserved aspartate residue that forms a covalent ester intermediate with the substrate.

03

Biological functions

DehalogenationXenobiotic metabolismBioremediationHydrolysis of carbon-halogen bonds
04

Disease associations

Other
05

Safety considerations

Lack of human orthologsLimited therapeutic relevance in human medicinePotential for environmental toxicity if microbial degradation pathways are disrupted

Beyond the preview

Go deeper on 2-haloacid dehalogenase (2-HAD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-haloacid dehalogenase (2-HAD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call